Mount Sinai Medical Center
New York, 10029, United States
NCT Number: NCT01384227
The overall objective of this study is to obtain data to evaluate whether high-resolution imaging of barrett's esophagus in vivo can assist clinicians in detecting dysplastic (precancerous) areas. This is a pilot study of an novel technology, a miniaturized microscope device which can be used during upper endoscopy to image the gastrointestinal epithelium. This is an exploratory, not a comparative, study designed to evaluate the feasibility of using this instrument in Barrett's esophagus.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Early Phase 1
New York, 10029, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Proflavine hemisulfate 0.01% (derived from dissolving 10 mg Proflavine Hemisulfate USP in 100 ml of sterile water)
Other names: Proflavine
Time frame: 1 day
Anandasabapathy, Sharmila, M.D.
Indiv
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04880044
Barrett Esophagus, Barrett's Esophagus
Cleveland, Ohio, United States
View Trial DetailsNCT04408105
Adenocarcinoma Of Esophagus, Barrett Esophagus
Aurora, Colorado, United States
View Trial DetailsNCT02534233
Barrett Esophagus, Barrett's Esophagus
Baltimore, Maryland, United States
View Trial DetailsNCT05965921
Barrett Esophagus, Barrett's Esophagus
Portsmouth, Hampshire, United Kingdom
View Trial Details